Red mold rice ameliorates impairment of memory and learning ability in intracerebroventricular amyloid β-infused rat by repressing amyloid β accumulation

Journal of Neuroscience Research

Volumn 85, Issue 14, 2007, Pages 3171-3182

  Lee, Chun Lin ^a   Kuo, Tzong Fu ^a   Wang, Jyh Jye ^b   Pan, Tzu Ming ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TAJEN UNIVERSITY   (Taiwan)

Author keywords

Alzheimer's disease; Amyloid; Lovastatin; Memory; Monacolin K; Monascus; Red mold rice; Water maze

Indexed keywords

ACETIC ACID; ACETYLCHOLINESTERASE; AMYLOID BETA PROTEIN[1-40]; LIPID PEROXIDASE; MEVINOLIN; PLANT EXTRACT; REACTIVE OXYGEN METABOLITE; RED MOLD RICE EXTRACT; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN CORTEX; BRAIN VENTRICLE; CELL STRAIN; CONTROLLED STUDY; DIETARY INTAKE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFLAMMATION; LEARNING DISORDER; LIPID PEROXIDATION; MALE; MAZE TEST; MEMORY DISORDER; MONASCUS; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT; RECOMMENDED DRUG DOSE; RED MOLD RICE; RICE; RISK FACTOR; WORKING MEMORY;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANALYSIS OF VARIANCE; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BRAIN; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; INJECTIONS, INTRAVENTRICULAR; LEARNING; LOVASTATIN; MALE; MAZE LEARNING; MEMORY DISORDERS; NERVE TISSUE PROTEINS; ORYZA SATIVA; PC12 CELLS; PEPTIDE FRAGMENTS; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, WISTAR;

EID: 35848966342     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21428     Document Type: Article

References (45)

1. Akihisa T, Tokuda H, Yasukawa K, Ukiya M, Kiyota A, Sakamoto N, Suzuki T, Tanabe N, Nishino H. 2005. Azaphilones, furanoisophthalides, and amino acids from the extracts of Monascus pilosus-fermented rice (red-mold rice) and their chemopreventive effects. J Agric Food Chem 53:562-565.
2. Aniya Y, Yokomakura T, Yonamine M, Shimada K, Nagamine T, Shimabukuro M, Gibo H. 1999. Screening of antioxidant action of various molds and protection of Monascus anka against experimentally induced liver injuries of rats. Gen Pharmacol 32:225-231.
3. Aniya Y, Ohtani II, Higa T, Miyagi C, Gibo H, Shimabukuro M, Nakanishi H, Taira J. 2000. Dimerumic acid as an antioxidant of the mold, Monascus anka. Free Radic Biol Med 28:999-1004.
4. Arendt T, Bigl V, Tennstedt A, Arendt A. 1984. Correlation between cortical plaque count and neuronal loss in the nucleus basalis in Alzheimer's disease. Neurosci Lett 48:81-85.
5. Beers RFJ, Sizer IW. 1952. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem 195:133-140.
6. Boyd E. 1935. The growth of the surface area of human body. Minneapolis: University of Minnesota Press.
7. Chauhan NB, Siegel GJ, Feinstein DL. 2004. Effects of lovastatin and pravastatin on amyloid processing and inflammatory response in TgCRND8 brain. Neurochem Res 29:1897-1911.
8. Choi SJ, Kim MJ, Heo HJ, Kim HK, Hong B, Kim CJ, Kim BG, Shin DH. 2006. Protective effect of Rosa laevigata against amyloid beta peptide-induced oxidative stress. Amyloid 13:6-12.
9. Cordle A, Koenigsknecht-Talboo J, Wilkinson B, Limpert A, Landreth G. 2005. Mechanisms of statin-mediated inhibition of small G-protein function. J Biol Chem 280:34202-34209.
10. Darvesh S, Martin E, Walsh R, Rockwood K. 2004. Differential effects of lipid-lowering agents on human cholinesterases. Clin Biochem 37:42-49.
11. Endo A. 1979. Monacolin K, a new hypocholesterolemic agent produced by a Monascus species. J Antibiotics (Tokyo) 32:852-854.
12. 15N]nitrate in biological fluids. Anal Biochem 126:131-138.
13. Grutzendler J, Morris JC. 2001. Cholinesterase inhibitors for Alzheimer's disease. Drugs 61:41-52.
14. Hashimoto M, Hossain S, Agdul H, Shido O. 2005. Docosahexaenoic acid-induced amelioration on impairment of memory learning in amyloid beta-infused rats relates to the decreases of amyloid beta and cholesterol levels in detergent-insoluble membrane fractions. Biochim Biophys Acta 1738:91-98.
15. Jang JH, Aruoma OI, Jen LS, Chung HY, Surh YJ. 2004. Ergothioneine rescues PC12 cells from beta-amyloid-induced apoptotic death. Free Radic Biol Med 36:288-299.
16. Journoud M, Jones PJ. 2004. Red yeast rice: a new hypolipidemic drug. Life Sci 74:2675-2683.
17. Juzlova P, Martinkova L, Kren V. 1996a. Secondary metabolites of the fungus Monascus: a review. J Ind Microbiol Biotechnol 16:163-170.
18. Juzlova P, Rezanka T, Martinkova L, Kren V. 1996b. Long-chain fatty acids from Monascus purpureus. Phytochemistry 43:151-153.
19. Kar S, Issa AM, Seto D, Auld DS, Collier B, Quirion R. 1998. Amyloid beta-peptide inhibits high-affinity choline uptake and acetylcholine release in rat hippocampal slices. J Neurochem 70:2179-2187.
20. Krall WJ, Sramek JJ, Cutler NR. 1999. Cholinesterase inhibitors: a therapeutic strategy for Alzheimer disease. Ann Pharmacother 33:441-450.
21. Kunjathoor VV, Tseng AA, Medeiros LA, Khan T, Moore KJ. 2004. Beta-amyloid promotes accumulation of lipid peroxides by inhibiting CD36-mediated clearance of oxidized lipoproteins. J Neuroinflammation 1:23.
22. Lee CL, Tsai TY, Wang JJ, Pan TM. 2006a. In vivo hypolipidemic effects and safety of low dosage Monascus powder in a hamster model of hyperlipidemia. Appl Microbiol Biotechnol 70:533-540.
23. Lee CL, Wang JJ, Kuo SL, Pan TM. 2006b. Monascus fermentation of dioscorea for increasing the production of cholesterol-lowering agent-monacolin K and antiinflammation agent-monascin. Appl Microbiol Biotechnol 72:1254-1262.
24. Lee CL, Wang JJ, Pan TM. 2006c. Synchronous analysis method for detection of citrinin and the lactone and acid forms of monacolin K in red mold rice. JAOAC Int 89:669-677.
25. Lee CL, Wang JJ, Pan TM. 2006d. Monascus extract repress the toxicity of Alzheimer's risk factor - amyloid β-protein in PC-12 cell model. Proc Ann Meeting Inst Food Technologist 078G-01.
26. Li L, Cao D, Kim H, Lester R, Fukuchi K. 2006. Simvastatin enhances learning and memory independent of amyloid load in mice. Ann Neurol 60:729-739.
27. Long MS, Hong Y, Zhou XH, Yang Y. 2006. Anti-dementia effects of grape peel extracts experiment study. Wei Sheng Yan Jiu 35:300-303.
28. Ma J, Li Y, Ye Q, Li J, Hua Y, Ju D, Zhang D, Cooper R, Chang M. 2000. Constituents of red yeast rice, a traditional Chinese food and medicine. J Agric Food Chem 48:5220-5225.
29. Morris R. 1984. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11:47-60.
30. Nabeshima T, Nitta A. 1994. Memory impairment and neuronal dysfunction induced by beta-amyloid protein in rats. Tohoku J Exp Med 174:241-249.
31. Ohkawa H, Ohishi N, Yagi K. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358.
32. Paxinos G, Watson C. 2005. The rat brain in stereotaxic coordinates: the new coronal set. London: Elsevier Academic.
33. Pollack SJ, Sadler, II, Hawtin SR, Tailor VJ, Shearman MS. 1995. Sulfated glycosaminoglycans and dyes attenuate the neurotoxic effects of beta-amyloid in rat PC12 cells. Neurosci Lett 184:113-116.
34. Rhyu MR, Kim DK, Kim HY, Kim BK. 2000. Nitric oxide-mediated endothelium-dependent relaxation of rat thoracic aorta induced by aqueous extract of red rice fermented with Monascus ruber. J Ethnopharmacol 70:29-34.
35. Schubert D, Behl C, Lesley R, Brack A, Dargusch R, Sagara Y, Kimura H. 1995. Amyloid peptides are toxic via a common oxidative mechanism. Proc Natl Acad Sci U S A 92:1989-1993.
36. Scott HD, Laake K. 2001. Statins for the prevention of Alzheimer's disease. Cochrane Database Syst Rev CD003160.
37. Stephan A, Phillips AG. 2005. A case for a non-transgenic animal model of Alzheimer's disease. Genes Brain Behav 4:157-172.
38. Su YC, Wang JJ, Lin TT, Pan TM. 2003. Production of the secondary metabolites gamma-aminobutyric acid and monacolin K by Monascus. J Ind Microbiol Biotechnol 30:41-46.
39. Sweeney WA, Luedtke J, McDonald MP, Overmier JB. 1997. Intrahippocampal injections of exogenous beta-amyloid induce postdelay errors in an eight-arm radial maze. Neurobiol Learn Mem 68:97-101.
40. Townsend KP, Pratico D. 2005. Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs. FASEB J 19:1592-1601.
41. Van Lenten BJ, Wagner AC, Nayak DP, Hama S, Navab M, Fogelman AM. 2001. High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection. Circulation 103:2283-2288.
42. Wang JJ, Shieh MJ, Kuo SL, Lee CL, Pan TM. 2006. Effect of red mold rice on antifatigue and exercise-related changes in lipid peroxidation in endurance exercise. Appl Microbiol Biotechnol 70:247-253.
43. Yamada K, Ren X, Nabeshima T. 1999. Perspectives of pharmacotherapy in Alzheimer's disease. Jpn J Pharmacol 80:9-14.
44. Yamaguchi Y, Miyashita H, Tsunekawa H, Mouri A, Kim HC, Saito K, Matsuno T, Kawashima S, Nabeshima T. 2006. Effects of a novel cognitive enhancer, spiro[imidazo-[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET1446), on learning impairments induced by amyloid-beta1-40 in the rat. J Pharmacol Exp Ther 317:1079-1087.
45. Zheng L, Roberg K, Jerhammar F, Marcusson J, Terman A. 2006. Oxidative stress induces intralysosomal accumulation of Alzheimer amyloid beta-protein in cultured neuroblastoma cells. Ann N Y Acad Sci 1067:248-251.